A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access ...

However, in some families, this pathology can also occur together with retinitis pigmentosa, an inherited vision disease. Now ...

Considering taking supplements to treat retinitis pigmentosa? Below is a list of common natural remedies used to treat or reduce the symptoms of retinitis pigmentosa. Follow the links to read ...

"Verana Health’s Qdata Retinitis Pigmentosa offers valuable insights into disease progression, patient demographics, and treatment outcomes, enabling us to refine our clinical development ...